Expert Opinion on Emerging Drugs

Papers
(The H4-Index of Expert Opinion on Emerging Drugs is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Emerging and traditional 5-α reductase inhibitors and androgen receptor antagonists for male androgenetic alopecia27
New drugs targeting calcitonin gene-related peptide for the management of migraines27
Emerging immune tolerance therapies for neuromyelitis optica spectrum disorder26
Combined chemo-immunotherapy in advanced non-small cell lung cancer: feasible in the elderly?20
A review of phase II and III drugs for the treatment and management of endometriosis18
Emerging drugs for the treatment of acne: a review of phase 2 & 3 trials16
Muscarinic M1 and M4 agents as treatments for schizophrenia: what do they do and who do they do it for?15
Evolving role of VIADISC for chronic low back and discogenic pain: a narrative review15
How can we prevent diarrhea induced by systemic treatments in oncological patients? An evaluation of phase II trials15
Future treatments for myelin oligodendrocyte glycoprotein antibody-associated disease: the clinical trial landscape15
Emerging medicines to improve the basic defect in cystic fibrosis15
Emerging biological treatments for asthma12
0.094533920288086